1. Home
  2. CPIX vs NRXS Comparison

CPIX vs NRXS Comparison

Compare CPIX & NRXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cumberland Pharmaceuticals Inc.

CPIX

Cumberland Pharmaceuticals Inc.

HOLD

Current Price

$7.68

Market Cap

98.3M

Sector

Health Care

ML Signal

HOLD

Logo Neuraxis Inc.

NRXS

Neuraxis Inc.

HOLD

Current Price

$7.69

Market Cap

78.9M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
CPIX
NRXS
Founded
1999
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
98.3M
78.9M
IPO Year
2007
2023

Fundamental Metrics

Financial Performance
Metric
CPIX
NRXS
Price
$7.68
$7.69
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
★ $13.00
AVG Volume (30 Days)
48.6K
★ 128.0K
Earning Date
05-05-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 58.70
22.13
EPS
N/A
★ N/A
Revenue
★ $42,010,949.00
$3,569,282.00
Revenue This Year
N/A
$172.91
Revenue Next Year
N/A
$115.71
P/E Ratio
N/A
★ N/A
Revenue Growth
16.75
★ 32.89
52 Week Low
$1.85
$2.21
52 Week High
$9.28
$9.33

Technical Indicators

Market Signals
Indicator
CPIX
NRXS
Relative Strength Index (RSI) 52.59 67.04
Support Level $7.34 $6.60
Resistance Level $8.27 $7.70
Average True Range (ATR) 0.46 0.48
MACD 0.12 0.18
Stochastic Oscillator 60.67 84.00

Price Performance

Historical Comparison
CPIX
NRXS

About CPIX Cumberland Pharmaceuticals Inc.

Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment, which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The firm promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. Its brands include Acetadote, Caldolor, Kristalose, Sancuso, Vaprisol, and Vibativ. Geographically, the company generates revenue from China, South Korea, Russia, Mexico, Australia, and Saudi Arabia.

About NRXS Neuraxis Inc.

Neuraxis Inc is a growth stage company is engaged in developing neuromodulation therapies to address chronic and debilitating conditions in children. The company is dedicated to advancing the science with its' proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology. The company focuses on targeted therapies for the pediatric and adolescent population suffering from disorders of gut-brain interaction (DGBIs).

Share on Social Networks: